Medicover ABLTS:0RPS +0.42%89 Days Payable is 39.71 as of Mar. 2026, which is 96% above its 10-year median of 20.24. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr233.91 (Fairly Valued). The stock has 5 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Medicover AB ranks worse than 59.31% on this metric.
The historical rank and industry rank for Medicover AB's Days Payable or its related term are showing as below:
LTS:0RPS'
s Days Payable Range Over the Past 10 Years
Min: 16.84 Med: 20.24 Max: 46.94
Current: 46.94
During the past 12 years, Medicover AB's highest Days Payable was 46.94. The lowest was 16.84. And the median was 20.24.
LTS:0RPS's Days Payable is ranked worse than 59.31% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs LTS:0RPS: 46.94
Medicover AB's Days Payable
increased
from Mar. 2025 (35.74) to Mar. 2026 (39.71).
It may suggest that Medicover ABdelayed paying its suppliers.
Medicover AB Days Payable Related Terms
Medicover AB Days Payable Historical Data
* Premium members only.
The historical data trend for Medicover AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RPS vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Medicover AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicover AB Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Medicover AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medicover AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicover AB (LTS:0RPS) has a Days Payable of 39.71 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicover AB and its competitors. This is 96% above median its historical median of 20.24. Over the past decade, Medicover AB's Days Payable has ranged from 16.84 to 46.94. According to the industry distribution chart, Medicover AB ranks #360 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 59.3%.
Is Medicover AB's Days Payable too high?
Medicover AB's current Days Payable of 39.71 is 96% above median its 10-year median of 20.24. Over the past 10 years, this metric has ranged from a low of 16.84 to a high of 46.94. The Healthcare Providers & Services industry median Days Payable is 58.00. Medicover AB's value of 39.71 is 31.5% below this industry median. Based on the distribution chart, Medicover AB ranks #360 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #360 out of 607 companies for Days Payable. This places Medicover AB in the lower half of its industry. The industry median Days Payable is 58.00. Medicover AB's value of 39.71 is 31.5% below this benchmark. Historically, Medicover AB's own Days Payable has ranged from 16.84 to 46.94 over the past decade. While the company's 10-year median is 20.24 vs. the industry median of 58.00, Medicover AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicover AB's current Days Payable of 39.71 is 31.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current Days Payable is 39.71, which is 96% above median its own 10-year median of 20.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.91, compared to a current price of kr238.00 — trading 1.7% above its estimated fair value. The current Days Payable is 39.71, which is 96% above median its 10-year median of 20.24 and 31.5% below the Healthcare Providers & Services industry median of 58.00. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Days Payable is 39.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicover AB (LTS:0RPS) Overvalued in 2026?
Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued.
The current stock price of kr238.00 is trading 1.7% above its estimated GF Value™ of kr233.91.
GuruFocus considers Medicover AB to be Fairly Valued.
Key valuation signals for LTS:0RPS:
Days Payable: 39.71 (96% above median its 10-year median of 20.24)
GF Value™: kr233.91 vs. price of kr238.00 (1.7% above fair value)
Industry Position: 31.5% below the Healthcare Providers & Services median (#360 of 607)
No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score
Get the complete analysis for LTS:0RPS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RPS has been successfully added to your 
